LABA/LAMA fixed-dose combinations LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis

LABA/LAMA fixed-dose combinations LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis

Background: Long-acting muscarinic antagonist (LAMA) monotherapy is recommended for chronic obstructive pulmonary disease (COPD) patients with high risk of exacerbations. It is unclear whether long-acting β2-agonist (LABA)/LAMA fixed-dose combinations (FDCs) are more effective than LAMAs alone in pr...

Full description

Bibliographic Details
Main Authors: Ching-Yi Chen, Wang-Chun Chen, Chi-Hsien Huang, Yi-Ping Hsiang, Chau-Chyun Sheu, Yung-Che Chen, Meng-Chih Lin, Kuo-An Chu, Cheng-Hung Lee, Yu-Feng Wei
Format: Article
Language:English
Published: SAGE Publishing 2020-07-01
Series:Therapeutic Advances in Respiratory Disease
Online Access:https://doi.org/10.1177/1753466620937194

Internet

https://doi.org/10.1177/1753466620937194

Similar Items